Intrathymic injection of donor splenocytes plus systemic antilymphocyte serum or antilymphocyte serum alone prolongs cardiac allograft survival and inhibits graft arteriosclerosis in the Lewis-to-F344 chronic rejection model.

Shin, Y T

Intrathymic injection of donor splenocytes plus systemic antilymphocyte serum or antilymphocyte serum alone prolongs cardiac allograft survival and inhibits graft arteriosclerosis in the Lewis-to-F344 chronic rejection model. [electronic resource] - Transplantation proceedings Jun 1995 - 2112-4 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0041-1345


Animals
Antilymphocyte Serum--therapeutic use
Chronic Disease
Coronary Artery Disease--prevention & control
Graft Occlusion, Vascular--prevention & control
Graft Rejection--prevention & control
Graft Survival
Heart Transplantation--immunology
Immunosuppression Therapy--methods
Male
Rats
Rats, Inbred F344
Rats, Inbred Lew
Spleen--immunology
Thymus Gland--immunology
Tissue Donors